66,504 Shares in Everus (NYSE:ECG) Bought by JPMorgan Chase & Co.

JPMorgan Chase & Co. acquired a new stake in shares of Everus (NYSE:ECGFree Report) during the fourth quarter, Holdings Channel.com reports. The firm acquired 66,504 shares of the company’s stock, valued at approximately $4,373,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. bought a new stake in Everus during the 4th quarter valued at $365,965,000. American Century Companies Inc. bought a new stake in shares of Everus in the fourth quarter valued at about $49,650,000. Hennessy Advisors Inc. bought a new stake in shares of Everus in the fourth quarter valued at about $31,611,000. US Bancorp DE bought a new position in Everus during the 4th quarter worth about $28,332,000. Finally, Charles Schwab Investment Management Inc. purchased a new position in Everus during the 4th quarter valued at about $27,031,000.

Everus Stock Performance

ECG stock opened at $38.77 on Friday. Everus has a one year low of $31.38 and a one year high of $77.93. The company has a current ratio of 1.58, a quick ratio of 1.50 and a debt-to-equity ratio of 0.47. The firm’s fifty day moving average price is $40.05.

Everus (NYSE:ECGGet Free Report) last posted its quarterly earnings data on Tuesday, February 11th. The company reported $0.67 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.73 by ($0.06). As a group, research analysts expect that Everus will post 2.49 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on ECG. Oppenheimer boosted their price objective on shares of Everus from $70.00 to $80.00 and gave the stock an “outperform” rating in a research note on Tuesday, January 7th. Stifel Nicolaus cut their price target on Everus from $67.00 to $55.00 and set a “buy” rating on the stock in a report on Wednesday, April 9th.

Read Our Latest Research Report on Everus

Insider Activity at Everus

In other Everus news, CFO Maximillian J. Marcy purchased 1,300 shares of Everus stock in a transaction dated Tuesday, February 25th. The shares were acquired at an average price of $38.99 per share, with a total value of $50,687.00. Following the completion of the transaction, the chief financial officer now owns 5,508 shares of the company’s stock, valued at $214,756.92. This trade represents a 30.89 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Rocca Michael Della purchased 1,050 shares of the company’s stock in a transaction on Tuesday, February 18th. The stock was acquired at an average price of $47.56 per share, with a total value of $49,938.00. Following the purchase, the director now owns 2,027 shares of the company’s stock, valued at approximately $96,404.12. This represents a 107.47 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders purchased 3,750 shares of company stock valued at $153,853. 0.21% of the stock is currently owned by insiders.

About Everus

(Free Report)

Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.

Read More

Want to see what other hedge funds are holding ECG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Everus (NYSE:ECGFree Report).

Institutional Ownership by Quarter for Everus (NYSE:ECG)

Receive News & Ratings for Everus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everus and related companies with MarketBeat.com's FREE daily email newsletter.